News & Videos - SUNSHINE BIOPHARMA SBFM

MONTREAL, QC / ACCESSWIRE / June 3, 2020 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer today announced that it has filed a patent application in the United States for a new treatment for Coronavirus infections, including COVID-19. Sunshine's patent application covers composition subject matter pertaining to small molecules for inhibition of the main...

...

...

MONTREAL, CANADA / ACCESSWIRE / December 17, 2018 / Sunshine Biopharma, Inc. (OTC PINK: "SBFM") today announced that it has received Health Canada approval for Essential 9TM, the first in a line of essential micronutrients products that the Company is planning to launch. On Friday December 14, 2018, Health Canada issued NPN 80089663 through which it authorized Sunshine Biopharma to manufacture and sell the Essential 9TM product. Essential 9TM are dietary supplement tablets that contain a...

MONTREAL, QC / ACCESSWIRE / December 12, 2018 / Sunshine Biopharma, Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer, today announced that it has signed an agreement with Crocus Laboratories Inc. (Crocus), a Montreal based company for assistance in the manufacturing of Adva-27a. Crocus will help Sunshine in the development of a large-scale process for the manufacturing of 2 to 5...

MONTREAL, QC / ACCESSWIRE / September 14, 2018 / Sunshine Biopharma, Inc. (OTC PINK: SBFM) (the "Company" or "Sunshine"), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer, today announced that it has entered into an Equity Financing Agreement ("Equity Financing Agreement") and Registration Rights Agreement ("Registration Rights Agreement") with GHS Investments LLC, a Nevada limited liability company...

MONTREAL, QC / ACCESSWIRE / August 16, 2018 / Sunshine Biopharma, Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer, today announced that it has signed a service agreement with Quintessential Biosciences, Inc. (Q Sciences) to register Q Sciences line of products with Health Canada. Sunshine Biopharma will perform the work for Q Sciences through its wholly owned Canadian service...

MONTREAL, QC / ACCESSWIRE / June 18, 2018 / Sunshine Biopharma, Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of cancer, today announced that it has purchased all of the necessary equipment for Microbiology Testing Service and will be launching the service through its wholly owned subsidiary, Atlas Pharma Inc. Presently, Atlas Pharma offers analytical chemistry testing. "This is in line with our stated plans...

MONTREAL, QB / ACCESSWIRE / May 10, 2018 / Sunshine Biopharma, Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development, and commercialization of drugs for the treatment of cancer and other acute and chronic indications, today announced that it has signed an agreement with Jitney Trade Inc. whereby the parties have agreed to extend the equity financing that was previously announced of up to $10,000,000 Canadian (approximately $8,000,000 US) (the "Offering") until...

MONTREAL, QB / ACCESSWIRE / January 4, 2018 / On January 1, 2018, Sunshine Biopharma Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development, and commercialization of drugs for the treatment of various forms of cancer, completed the acquisition of Atlas Pharma Inc., a Montreal-based analytical chemistry company fully accredited by Health Canada and registered with the FDA. Atlas Pharma is a certified company dedicated to chemical analysis of pharmaceutical and other...

MONTREAL, QC / ACCESSWIRE / September 19, 2017 / Sunshine Biopharma Inc. (OTC PINK: SBFM), a pharmaceutical company focused on the research, development, and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed negotiations of the terms of the previously announced private placement with its exclusive placement agent, Jitney Trade Inc. The offering will consist of up to 400,000,000 shares of the Company's Common Stock at a price of $0.025...

MONTREAL, QC / ACCESSWIRE / June 26, 2017 / Sunshine Biopharma Inc. (OTC PINK: SBFM) is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead anticancer compound, Adva-27a, has proven effective at killing Multidrug Resistant Cancer cells including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells and Uterine Sarcoma cells (Results published in ANTICANCER RESEARCH,...

MONTREAL, QC / ACCESSWIRE / June 19, 2017 / Sunshine Biopharma Inc. (OTC PINK: SBFM), a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications, is pleased to announce that it has filed an application for a Drug Establishment License ("DEL") with Health Canada, the Canadian equivalent of the FDA in the United States. Obtaining a DEL is the first step in the certification process of a company to be able to...

MONTREAL, QC / ACCESSWIRE / January 11, 2017 / Sunshine Biopharma Inc. (OTC PINK: SBFM), a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications, is pleased to announce that it currently has twenty-three additional Generic Pharmaceuticals under review for in-licensing. When completed, this will bring the Company's Generic Products portfolio to a total of twenty-seven. A larger products portfolio provides...

MONTREAL, QC / ACCESSWIRE / December 9, 2016 / Sunshine Biopharma Inc. (OTC PINK: SBFM), a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications, is pleased to announce that it has signed a Strategic Alliance Agreement with Atlas Pharma Inc., a fully certified Montreal-based company offering Analytical Testing and other services to the pharmaceutical industry. Pursuant to the Agreement Sunshine and Atlas...